Skip to main content
. Author manuscript; available in PMC: 2020 Apr 8.
Published in final edited form as: J Heart Lung Transplant. 2019 May 7;38(8):845–855. doi: 10.1016/j.healun.2019.05.001

Table 4.

KEGG pathways enriched with ACR

Term Fold Enrichment Genes p Value FDR
T-cell receptor signaling pathway 21.5 CD247, CD3e, CD8a, CD8b, GRAP2, ITK, LCK, CTLA4, IFNG, PDCD1, ZAP70 2.70E-11 2.90 E-10
Natural killer cell mediated cytotoxicity 17.2 CD247, FASLG, LCK, SH2D1A, GZMB, IFNG, KLRK1, PRF1, ZAP70 2.40E-08 2.60E-07
Primary immunodeficiency 27.9 CD3E, CD8A, CD8B, LCK, ZAP70 2.40E-05 2.60E-04
Cell adhesion molecules 8.7 CD8a, CD8b, TIGIT, CTLA4, PDCD1, VCAM1 4.90E-04 0.0052
Cytokine-cytokine receptor interaction 6.5 CXCL13, CXCR3, CXCR6, FASLG, IFNG, IL2RB 4.90E-04 0.0052
Graft-versus-host disease 24.3 FASLG, GZMB, IFNG, PRF1 5.10E-04 0.0055
Allograft rejection 22.4 FASLG, GZMB, IFNG, PRF1 6.60E-04 0.0070